Clarity Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	802	527	1,127	121	91	-
Market Cap Growth	8.84%	-53.25%	828.01%	33.99%	-	-
Enterprise Value	742	454	1,102	71	24	-
Last Close Price	2.27	1.74	3.73	0.49	-	-
PS Ratio	129.33	84.93	146.79	18.62	20.37	-
PB Ratio	13.56	8.91	11.55	2.64	1.43	-
P/TBV Ratio	13.56	8.91	11.55	2.64	1.43	-
EV/Sales Ratio	110.23	73.18	143.49	10.87	5.40	-
Asset Turnover	0.07	0.07	0.10	0.11	0.11	0.20
Quick Ratio	9.08	9.08	18.44	9.95	13.19	9.91
Current Ratio	9.69	9.69	19.05	10.17	13.26	10.00
Return on Equity (ROE)	-54.37%	-54.37%	-39.28%	-30.48%	-42.23%	-71.89%
Return on Assets (ROA)	-33.76%	-33.76%	-23.87%	-18.65%	-17.41%	-40.63%
Return on Capital Employed (ROCE)	-76.10%	-76.10%	-30.20%	-38.00%	-18.50%	-50.60%
Earnings Yield	-5.25%	-8.00%	-2.51%	-13.48%	-18.06%	-
FCF Yield	-4.49%	-6.84%	-2.59%	-15.10%	-10.28%	-
Buyback Yield / Dilution	-16.86%	-16.86%	-5.22%	-4.81%	-40.37%	-20.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.